These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

252 related articles for article (PubMed ID: 1949738)

  • 21. Pulsed dexamethasone for refractory idiopathic thrombocytopenic purpura.
    Jantunen E; Nousiainen T
    Am J Hematol; 1996 Dec; 53(4):281-2. PubMed ID: 8948677
    [No Abstract]   [Full Text] [Related]  

  • 22. [What is certain in the treatment with immunosuppressive agents?].
    Malchow H
    Internist (Berl); 1971 Dec; 12(12):504-12. PubMed ID: 4944681
    [No Abstract]   [Full Text] [Related]  

  • 23. [Thymopentin in a case of autoimmune thrombocytopenia secondary to chronic lymphatic leukemia].
    Cantore M; Bucalossi A; Butini P; Carnevali A; Cavion MA; Leoncini L
    G Clin Med; 1989; 70(6-7):421, 423, 425. PubMed ID: 2670653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of mycophenolate mofetil for chronic, refractory immune cytopenias in children with autoimmune lymphoproliferative syndrome.
    Rao VK; Dugan F; Dale JK; Davis J; Tretler J; Hurley JK; Fleisher T; Puck J; Straus SE
    Br J Haematol; 2005 May; 129(4):534-8. PubMed ID: 15877736
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination chemotherapy in a patient with severe multiple systemic autoimmune disease.
    Tamai Y; Takami H; Akagi T; Kawamura S; Munakata A
    Clin Lab Haematol; 1998 Oct; 20(5):315-6. PubMed ID: 9807680
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunosuppressive long-term therapy of autoimmune diseases in hematology].
    Nelius D; Stieglitz R
    Z Gesamte Inn Med; 1972 Jun; 27(11):480-3. PubMed ID: 4626749
    [No Abstract]   [Full Text] [Related]  

  • 27. [Characteristics of a clinical course of immune cytopenias with a high titer of autoantibodies to the microsomal antigen of the thyroid gland].
    Vinogradova IuE; Shinkarkina AP; Vinogradov DL; Poverennyĭ AM
    Ter Arkh; 2004; 76(7):81-5. PubMed ID: 15379134
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Thymalin in the combined treatment of patients with chronic lympholeukemia].
    Babenko TF; Antonenko VT; SkuratovskiUi MF
    Vrach Delo; 1989 Mar; (3):47-9. PubMed ID: 2750120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rituximab is effective in the management of refractory autoimmune cytopenias occurring after allogeneic stem cell transplantation.
    Raj K; Narayanan S; Augustson B; Ho A; Mehta P; Duncan N; Tauro S; Mahendra P; Craddock C; Mufti G
    Bone Marrow Transplant; 2005 Feb; 35(3):299-301. PubMed ID: 15568036
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inflammatory and autoimmune complications of common variable immune deficiency.
    Knight AK; Cunningham-Rundles C
    Autoimmun Rev; 2006 Feb; 5(2):156-9. PubMed ID: 16431351
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunosuppressive therapy.
    Winkelstein A; Segel D; Stolzer BL; Fogel M; Shadduck RK; Lewis M
    Am J Med Sci; 1973 Feb; 265(2):92-108. PubMed ID: 4736193
    [No Abstract]   [Full Text] [Related]  

  • 32. Targeted ITP strategies: do they elucidate the biology of ITP and related disorders?
    Bennett CM; de Jong JL; Neufeld EJ
    Pediatr Blood Cancer; 2006 Oct; 47(5 Suppl):706-9. PubMed ID: 16933263
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of rituximab for systemic lupus erythematosus-associated immune cytopenias: A multicenter retrospective cohort study of 71 adults.
    Serris A; Amoura Z; Canouï-Poitrine F; Terrier B; Hachulla E; Costedoat-Chalumeau N; Papo T; Lambotte O; Saadoun D; Hié M; Blanche P; Lioger B; Gottenberg JE; Godeau B; Michel M
    Am J Hematol; 2018 Mar; 93(3):424-429. PubMed ID: 29247540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Immunosuppressive agents or splenectomy in hematologic autoaggressive diseases? Clinical experiment report].
    Mey U
    Z Gesamte Inn Med; 1972 Mar; 27(6):250-4. PubMed ID: 5065518
    [No Abstract]   [Full Text] [Related]  

  • 35. Longterm clinical and immunological effects of anti-CD20 treatment in patients with refractory systemic lupus erythematosus.
    Lindholm C; Börjesson-Asp K; Zendjanchi K; Sundqvist AC; Tarkowski A; Bokarewa M
    J Rheumatol; 2008 May; 35(5):826-33. PubMed ID: 18398943
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Successful treatment of Evans syndrome post liver transplant with splenectomy and switch from tacrolimus to cyclosporine.
    Domenech C; Mialou V; Galambrun C; Lachaux A; Mure P; Dijoud F; Bertrand Y
    Transpl Int; 2008 Apr; 21(4):397-9. PubMed ID: 18167150
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diagnosis of autoimmune diseases in hematology].
    Guisasola FJ; del Real M; Solís P; Blanco A; Bachiller RM
    An Esp Pediatr; 1985 Aug; 23(2):131-7. PubMed ID: 3904558
    [No Abstract]   [Full Text] [Related]  

  • 38. Incidence of anti-mouse antibodies in thrombocytopenic patients with autoimmune disorders.
    Clofent-Sanchez G; Laroche-Trainean J; Lucas S; Rispal P; Pellegrin JL; Nurden P; Nurden A
    Hum Antibodies; 1997; 8(2):50-9. PubMed ID: 9289388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Immunosuppressive treatment of autoimmune hemolytic anemia].
    Kardaszewicz E; Harbut-gryłka H
    Pol Tyg Lek; 1975 Jan; 30(3):109-11. PubMed ID: 1110950
    [No Abstract]   [Full Text] [Related]  

  • 40. [Immunosuppressive treatments of patients with autoimmune disorders].
    Wasastjerna C
    Nord Med; 1967 Nov; 78(45):1469-75. PubMed ID: 6070858
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.